1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. BEAM THERAPEUTICS INC
Beam Therapeutics Inc
XNAS: BEAM
27.53 -0.86 (-3.03%)
1.9M
XNAS Volume

XNAS 17 Jul, 2026 4:06 PM (EDT)

Watchlist

Portfolio

Alert

Beam Therapeutics Inc - BEAM - stock price prediction, stock price target, analyst ratings from 16 analysts

Beam Therapeutics Inc has a share price target of US$ 51, revenue growth forecast of -45.8%, and profit growth estimate of -478.8% for FY26, based on top 16 analyst calls.